Company: INMB
Filing Date: 2025-03-07
Form Type: 424B5
Source: 0001213900-25-021719
Chunk: 46

Company: Inmune Bio, Inc.
Filing Date: 2025-03-07
Form: 424B5
Chunk 46
---
 the exhibits to the registration statement, at the SEC’s Public Reference Room located at 100 F Street, N.E., Washington D.C.
20549. You may obtain further information on the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. Our SEC
filings are also available to the public at the SEC’s web site at www.sec.gov. These documents may also be accessed on our web
site at www.inmunebio.com. Information contained on our web site is not incorporated by reference into this prospectus and you should
not consider information contained on our web site to be part of this prospectus.

This prospectus and any prospectus
supplement are part of a registration statement filed with the SEC and do not contain all of the information in the registration statement.
The full registration statement may be obtained from the SEC or us as indicated above. Other documents establishing the terms of the offered
securities are filed as exhibits to the registration statement or will be filed through an amendment to our registration statement on
Form S-3 or under cover of a Current Report on Form 8-K and incorporated into this prospectus by reference.

<div align='center'>13

INCORPORATION OF CERTAIN DOCUMENTS BY REFERENCE</div>

The SEC allows us to “incorporate by reference” into this prospectus the information we file with it, which means that we can disclose important information to you by referring you to those documents. The information incorporated by reference is considered to be part of this prospectus. Any statement contained herein or in a document incorporated or deemed to be incorporated by reference into this document will be deemed to be modified or superseded for purposes of the document to the extent that a statement contained in this document or any other subsequently filed document that is deemed to be incorporated by reference into this document modifies or supersedes the statement. We incorporate by reference in this prospectus the following information (other than, in each case, documents or information deemed to have been furnished and not filed in accordance with SEC rules):

| ● | the description of our common stock contained in our                                                                              
 Registration Statement on Form 8-A                                                                                                
 filed with the SEC on February 1, 2019 (File No. 001-38793), as amended by Exhibit                                                
 4.1 to our Annual Report on Form                                                                                                  
 10-K filed on March 3, 2022, including any subsequent amendment or any report filed for the purpose of updating such